Patents by Inventor Barbara Beck

Barbara Beck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7816377
    Abstract: The invention relates to tubulysin derivatives of general formula (II), said derivatives having a cytostatic effect.
    Type: Grant
    Filed: July 9, 2003
    Date of Patent: October 19, 2010
    Assignee: R&D-Biopharmaceuticals GmbH
    Inventors: Alexander Dömling, Bernd Henkel, Barbara Beck, Katrin Illgen, Sukumar Sakamuri, Sanjay Menon
  • Publication number: 20050239713
    Abstract: The invention relates to tubulysin derivatives of general formula (II), said derivatives having a cytostatic effect.
    Type: Application
    Filed: July 9, 2003
    Publication date: October 27, 2005
    Applicant: R&D-Biopharmaceuticals Am
    Inventors: Alexander Domling, Bernd Henkel, Barbara Beck, Katrin Illgen, Sukumar Sakamuri, Sanjay Menon
  • Publication number: 20040102488
    Abstract: The present invention relates to new compounds of the general formula (I), 1
    Type: Application
    Filed: July 15, 2003
    Publication date: May 27, 2004
    Inventors: Barbara Beck, Alexander Domling
  • Patent number: 6699883
    Abstract: The present invention relates to 3-pyrroloimidazole derivatives of the general formula (I) wherein the imidazole radical is an optionally substituted imidazole ring, X, Y, A and B are, each independently of the others, carbon or nitrogen atoms, the radicals Z denote, each independently of the others, a hydrogen atom, a halogen atom, a pseudohalogen, an optionally substituted alkyl, alkenyl, alkynyl, aralkyl, aralkenyl, aralkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, cycloaralkyl, cycloaralkenyl, cycloaralkynyl, aryl or alkoxy radical or an optionally substituted ring, to which one or two further, optionally substituted rings may be fused, and/or at least two of the radicals Z may be part of an optionally substituted ring, to which one or two further, optionally substituted rings may be fused, and to pharmaceutical compositions comprising at least one of the above-mentioned compounds, optionally in combination with carriers and/or adjuvants and/or excipients customary per se.
    Type: Grant
    Filed: April 4, 2002
    Date of Patent: March 2, 2004
    Assignee: Morphochem AG
    Inventors: Alexander Doemling, Barbara Beck